Zhejiang CONBA Pharmaceutical Co.,Ltd.

¥4.26As of Sun 8 Nov 2026, 12:00 UTC
SSE:600572Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (3.38%)
Div yield 3.52%
ROE 6.58%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.23
PE TTM 23.44
TSR TTM (5.59%)
Mkt cap ¥10.82B
ROIC 8.51%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥4.26
0.04%
(71.17%)
Hold 7|7|6|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.08
0.09
0.09
0.10
26.01%
40.70%
33.43%
30.82%
Revenue¥M
762.1
776.9
811.5
808.6
6.82%
12.22%
15.44%
11.38%
Peers (US$1.622B)
Cap (US$)
PE
1.629B
51.47x
1.622B
97.95x
Capital
TTM
5Y
10Y
Leveragex
0.712
1.836
1.664
EBIT/Intx
0.211
0.096
0.104
Own earn%
(242.06)
(56.94)
(55.69)
Sh yield%
24.58
43.68
43.93
Owners
Insiders/Inst%
14.21
51.45
Short interest%
5.06
SBC / revenue%
2.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
14–18
$1 testx
0.0
Incr. ROIC%
3